Literature DB >> 23698098

The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist.

Kazumitsu Sugiura1, Akemi Takemoto2, Michiya Yamaguchi2, Hidetoshi Takahashi3, Yukiko Shoda4, Teruyuki Mitsuma5, Kenshiro Tsuda6, Emi Nishida7, Yaei Togawa8, Kimiko Nakajima9, Akihiro Sakakibara10, Shigeo Kawachi11, Makoto Shimizu12, Yasutomo Ito13, Takuya Takeichi14, Michihiro Kono15, Yasushi Ogawa15, Yoshinao Muro15, Akemi Ishida-Yamamoto3, Shigetoshi Sano9, Hiroyuki Matsue8, Akimichi Morita7, Hitoshi Mizutani6, Hajime Iizuka3, Masahiko Muto2, Masashi Akiyama16.   

Abstract

Generalized pustular psoriasis (GPP) is a rare inflammatory skin disease that can be life-threatening. Recently, it has been reported that familial GPP is caused by homozygous or compound heterozygous mutations of IL36RN. However, the majority of GPP cases are sporadic and it is controversial whether IL36RN mutations are a causative/predisposing factor for sporadic GPP. We searched for IL36RN mutations in two groups of GPP patients in the Japanese population in this study: GPP without psoriasis vulgaris (PV), and GPP with PV. Eleven cases of GPP without PV (GPP alone) and 20 cases of GPP accompanied by PV (GPP with PV) were analyzed. Surprisingly, 9 out of 11 cases of GPP alone had homozygous or compound heterozygous mutations in IL36RN. In contrast, only 2 of 20 cases of GPP with PV had compound heterozygous mutations in IL36RN. The two cases of GPP with PV who had compound heterozygous mutations in IL36RN are siblings, and both cases had PV-susceptible HLA-A*0206. We determined that GPP alone is a distinct subtype of GPP and is etiologically distinguished from GPP with PV, and that the majority of GPP alone is caused by deficiency of the interleukin-36 receptor antagonist due to IL36RN mutations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23698098     DOI: 10.1038/jid.2013.230

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  50 in total

1.  Generalized pustular eruptions: time to adapt the disease taxonomy to the genetic architecture?

Authors:  Alexander A Navarini; Laurence Valeyrie-Allanore; Niovi Setta-Kaffetzi; Jonathan N Barker; Francesca Capon; Daniel Creamer; Jean-Claude Roujeau; Peggy Sekula; Michael A Simpson; Richard C Trembath; Maja Mockenhaupt; Catherine H Smith
Journal:  J Invest Dermatol       Date:  2013-08-16       Impact factor: 8.551

2.  Generalized pustular psoriasis triggered by amoxicillin in monozygotic twins with compound heterozygous IL36RN mutations: comment on the article by Navarini et al.

Authors:  Kazumitsu Sugiura; Yukiko Shoda; Masashi Akiyama
Journal:  J Invest Dermatol       Date:  2013-08-20       Impact factor: 8.551

3.  IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis.

Authors:  Andrew Johnston; Xianying Xing; Liza Wolterink; Drew H Barnes; ZhiQiang Yin; Laura Reingold; J Michelle Kahlenberg; Paul W Harms; Johann E Gudjonsson
Journal:  J Allergy Clin Immunol       Date:  2016-12-31       Impact factor: 10.793

4.  Clinical features of von Zumbusch type of generalized pustular psoriasis in children: a retrospective study of 26 patients in southwestern China.

Authors:  Qian Wang; Wei Liu; Lixia Zhang
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

5.  IL36RN mutations underlie impetigo herpetiformis.

Authors:  Kazumitsu Sugiura; Naoki Oiso; Shin Iinuma; Hiromasa Matsuda; Masako Minami-Hori; Akemi Ishida-Yamamoto; Akira Kawada; Hajime Iizuka; Masashi Akiyama
Journal:  J Invest Dermatol       Date:  2014-04-09       Impact factor: 8.551

Review 6.  Psoriasis: Past, Present, and Future.

Authors:  Allison C Billi; Johann E Gudjonsson; John J Voorhees
Journal:  J Invest Dermatol       Date:  2019-11       Impact factor: 8.551

7.  Interleukin-36 Receptor Antagonist Deficiency (DITRA) with a Novel IL36RN Homozygous Mutation c.200G > T (P.Cys67Phe) in a Young Colombian Woman.

Authors:  Andres F Zea-Vera; Felipe E Estupiñan-Lopez; Jaqueline Cifuentes-Burbano; Myriam J Vargas; Anilza Bonelo
Journal:  J Clin Immunol       Date:  2019-04-05       Impact factor: 8.317

8.  [Psoriasis vulgaris in children and adolescents. Pathogenesis, clinical picture and therapy].

Authors:  P H Höger; H Hamm
Journal:  Hautarzt       Date:  2015-04       Impact factor: 0.751

9.  CARD14 c.526G>C (p.Asp176His) is a significant risk factor for generalized pustular psoriasis with psoriasis vulgaris in the Japanese cohort.

Authors:  Kazumitsu Sugiura; Masahiko Muto; Masashi Akiyama
Journal:  J Invest Dermatol       Date:  2014-01-29       Impact factor: 8.551

Review 10.  Pustular Psoriasis: The Dawn of a New Era.

Authors:  Hervez Bachelez
Journal:  Acta Derm Venereol       Date:  2020-01-30       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.